Article info
Cervical Cancer
Prognostic Impact of Pretreatment Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography SUVmax in Patients With Locally Advanced Cervical Cancer
- Address correspondence and reprint requests to Simona Cima MD, Radiation Oncology Unit, Oncology Institute of Southern Switzerland, Ospedale Regionale Bellinzona e Valli, via Ospedale, 6500 Bellinzona CH, Switzerland. E-mail: simona.cima{at}eoc.ch, simonacima{at}libero.it.
Citation
Prognostic Impact of Pretreatment Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography SUVmax in Patients With Locally Advanced Cervical Cancer
Publication history
- Received October 9, 2017
- Accepted December 19, 2017
- First published March 1, 2018.
Online issue publication
June 18, 2019
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© 2018 by the International Gynecologic Cancer Society and the European Society of Gynaecological Oncology.